Related Experiment Video

Updated: Jun 21, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors

Sharif B Missiha1, Mario Ostrowski, E Jenny Heathcote

  • 1Division of Gastroenterology, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Gastroenterology
|May 13, 2008
PubMed

Insights

Chronic hepatitis C (CHC) progression to cirrhosis varies due to host and viral factors. Modifiable factors like alcohol and insulin resistance impact CHC progression, but reliable predictive models are lacking.

Area of Science:

  • Hepatology
  • Virology
  • Genetics

Background:

  • Hepatic complications of chronic hepatitis C (CHC) typically manifest after cirrhosis develops.
  • Cirrhosis progression in CHC is highly variable, influenced by numerous host and viral determinants.
  • Understanding these factors is crucial for managing CHC and preventing severe liver disease.

Purpose of the Study:

  • To review the factors influencing the progression of liver fibrosis in chronic hepatitis C.
  • To identify nonmodifiable and modifiable risk factors associated with disease advancement.
  • To highlight the current limitations in predicting CHC progression.

Main Methods:

  • Literature review of natural history studies on chronic hepatitis C.
  • Analysis of host factors (age, sex, race, genetics) and viral factors.
  • Examination of modifiable factors including alcohol, smoking, insulin resistance, and coinfections.

Main Results:

  • Nonmodifiable factors like age, sex, and race are associated with CHC progression.
  • Host genetic polymorphisms and viral characteristics play significant roles.
  • Potentially modifiable factors include excessive alcohol consumption, smoking, insulin resistance, and coinfections (hepatitis B, HIV-1, schistosomiasis).

Conclusions:

  • CHC progression is multifactorial, involving both inherent and external influences.
  • While some factors are unchangeable, others like lifestyle choices and coinfections can be managed.
  • Accurate predictive models for CHC disease progression are currently unavailable, necessitating further research.

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Related Concept Videos

Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...